FluoroPharma Medical Inc (FPMI)
0.0001
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
FluoroPharma Medical Total Liabilities (Quarterly): 10.51M for Dec. 31, 2016
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2016 | 10.51M |
September 30, 2016 | 10.32M |
June 30, 2016 | 10.96M |
March 31, 2016 | 9.912M |
December 31, 2015 | 8.699M |
September 30, 2015 | 8.958M |
June 30, 2015 | 7.416M |
March 31, 2015 | 5.973M |
December 31, 2014 | 5.617M |
September 30, 2014 | 5.516M |
June 30, 2014 | 4.496M |
March 31, 2014 | 3.275M |
December 31, 2013 | 2.972M |
September 30, 2013 | 2.824M |
June 30, 2013 | 0.574M |
March 31, 2013 | 0.2803M |
December 31, 2012 | 0.2355M |
September 30, 2012 | 0.143M |
June 30, 2012 | 0.2322M |
Date | Value |
---|---|
March 31, 2012 | 0.11M |
December 31, 2011 | 0.3804M |
September 30, 2011 | 0.4509M |
June 30, 2011 | 0.6167M |
March 31, 2011 | 0.0279M |
December 31, 2010 | 2.031M |
September 30, 2010 | 0.0561M |
June 30, 2010 | 0.0536M |
March 31, 2010 | 0.0513M |
December 31, 2009 | 0.0468M |
September 30, 2009 | 0.0467M |
June 30, 2009 | 0.0456M |
March 31, 2009 | 0.0432M |
December 31, 2008 | 0.0371M |
September 30, 2008 | 0.0361M |
June 30, 2008 | 0.0397M |
March 31, 2008 | 0.0461M |
December 31, 2007 | 0.039M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
RenovaCare Inc | 2.515M |
Xeno Transplants Corp | -- |
Entia Biosciences Inc | 2.406M |
Regenerx Biopharmaceuticals Inc | 3.931M |
OncoVista Innovative Therapies Inc | 6.651M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 0.3348M |
Shareholders Equity (Quarterly) | -10.18M |